Osteogenesis in cranial defects:: Reassessment of the concept of critical size and the expression of TGF-β isoforms

被引:102
|
作者
Gosain, AK
Song, LS
Yu, PR
Mehrara, BJ
Maeda, CY
Gold, LI
Longaker, MT
机构
[1] Med Coll Wisconsin, Dept Plast & Reconstruct Surg, Milwaukee, WI 53226 USA
[2] NYU Med Ctr, Dept Pathol, New York, NY 10016 USA
关键词
D O I
10.1097/00006534-200008000-00018
中图分类号
R61 [外科手术学];
学科分类号
摘要
Transforming growth factor-betas (TGF-beta) have been demonstrated to be upregulated during osteoblast function in vitro and during cranial suture fusion in vivo. The authors hypothesized that spontaneous reossification of calvarial defects was also associated with upregulation of TGF-beta. The present study was designed to (1) evaluate the concept of a critical-size defect within the calvaria in an adult guinea pig model and (2) investigate the association between the reossification of calvarial defects and TGF-beta upregulation. Paired circular parietal defects with diameters of 3 and 5 mm and single parietal defects with diameters of 8 or 12 mm were made in 45 six-month-old skeletally mature guinea pigs. Three animals per defect size were killed after survival periods of 3 days, 1 week, 4 weeks, 8 weeks, or 12 weeks. New bone ingrowth was evaluated by assessing for linear closure by a traditional linear method and by a modified cross-sectional area method using an image analysis system in which the thickness of new bone was taken into account. Immunohistochemistry was performed using rabbit polyclonal antibodies to localize TGF-beta 1, -beta 2. and -beta 3. All specimens were photographed, and the intensity of immunostaining was graded based on subjective photographic assessment by three independent reviewers. No defect demonstrated any measurable bone replacement after a survival period of 3 days. All 3- and 5-mm defects were completely reossified after 12 weeks based on the linear analysis of ne iv bone, indicating these defects to be less than critical size. However er, new bone formation in the 5-mm defects never exceeded a mean of 40 percent by cross-sectional area of new bone. Percent of new bone formation by cross-sectional area was significantly higher within 3-mm defects than in all larger defects 4 weeks after the craniotomy, reaching a mean of 89 percent new bone by 12 weeks. Persistent gaps were noted on linear analysis of the 8- and 12-mm wounds by 12 weeks. and mean percent new bone by cross-sectional area remained below 30 percent. Immunolocalization demonstrated osteogenic fronts at the advancing bone edge and the endocranial side, in which the osteoblasts stained strongly for ail isoforms of TGF-beta. The intensity of osteoblast expression waned considerably af-ter the majority of the defect had reossified. These data indicate that histometric analysis based on cross-sectional area more accurately reflects the osteogenic potential of a cranial defect than does linear inspection of defect closure. Although the interpretation of immunolocalization studies is highly subjective, independent assessment by three reviewers indicates that isoforms of TGF-beta were upregulated during a limited "window" of time corresponding to the period of active calvarial reossification, and expression of TGF-beta corresponded to osteoblast activity within osteogenic fronts.
引用
收藏
页码:360 / 371
页数:12
相关论文
共 50 条
  • [1] Osteogenesis in cranial defects:: Reassessment of the concept of critical size and the expression of TGF-β isoforms -: Discussion
    Hollinger, JO
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 106 (02) : 372 - 372
  • [2] Expression of TGF-β isoforms, TGF-β receptors, and Smad molecules at different stages of human glioma
    Kjellman, C
    Olofsson, SP
    Hansson, O
    Von Schantz, T
    Lindvall, M
    Nilsson, I
    Salford, LG
    Sjögren, HO
    Widegren, B
    INTERNATIONAL JOURNAL OF CANCER, 2000, 89 (03) : 251 - 258
  • [3] Osteoblast gene expression is differentially regulated by TGF-β isoforms
    Fagenholz, PJ
    Warren, SM
    Greenwald, JA
    Bouletreau, PJ
    Spector, JA
    Crisera, FE
    Longaker, MT
    JOURNAL OF CRANIOFACIAL SURGERY, 2001, 12 (02) : 183 - 190
  • [4] Transforming growth factor β isoforms (TGF-β1, TGF-β2, TGF-β3) messenger RNA expression in laryngeal cancer
    Kapral, Malgorzata
    Strzalka, Barbara
    Kowalczyk, Magorzata
    Jurzak, Magdalena
    Mazurek, Urszula
    Gierek, Tatiana
    Paluch, Jaroslaw
    Markowski, Jaroslaw
    Swiatkowska, Longina
    Weglarz, Ludmila
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2008, 29 (04) : 233 - 237
  • [5] Expression and secretion of TGF-β isoforms and expression of TGF-β-receptors I, II and III in normal and neoplastic human breast
    Chakravarthy, D
    Green, AR
    Green, VL
    Kerin, MJ
    Speirs, V
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (01) : 187 - 194
  • [6] Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cells
    Roth, S
    Gong, W
    Gressner, AM
    JOURNAL OF HEPATOLOGY, 1998, 29 (06) : 915 - 922
  • [7] Differential expression and localisation of TGF-β isoforms and receptors in the murine epididymis
    Voisin, Allison
    Damon-Soubeyrand, Christelle
    Bravard, Stephanie
    Saez, Fabrice
    Drevet, Joel R.
    Guiton, Rachel
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] Differential expression and localisation of TGF-β isoforms and receptors in the murine epididymis
    Allison Voisin
    Christelle Damon-Soubeyrand
    Stéphanie Bravard
    Fabrice Saez
    Joël R. Drevet
    Rachel Guiton
    Scientific Reports, 10
  • [9] Quantitative assessment of cranial defect healing and correlation with the expression of TGF-β
    Gosain, AK
    Song, LS
    Yu, PR
    Mehrara, BJ
    Maeda, CY
    Gold, LI
    Longaker, MT
    JOURNAL OF CRANIOFACIAL SURGERY, 2001, 12 (04) : 401 - 404
  • [10] Renal expression of fibrotic matrix proteins and of transforming growth factor-β (TGF-β) isoforms in TGF-β transgenic mice
    Mozes, MM
    Böttinger, EP
    Jacot, TA
    Kopp, JB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (02): : 271 - 280